# Nigeria Scales Up Malaria Vaccination Efforts to Protect Vulnerable Children

Targeted immunization programs in Nigeria show promising results in reducing child malaria mortality rates.

- **Source:** [eNCA](https://www.enca.com)
- **Published:** 2026-11-12
- **Topic:** [health](https://brifing.si/c/health)
- **Original article:** <https://www.enca.com/opinion/jab-jab-house-house-nigeria-slowly-rolls-out-malaria-vaccine>
- **On Brifing:** https://brifing.si/s/3e5530a2-ccc3-4183-a3a8-747a58b5d64c

## Vaccine Rollout Progress

Nigeria began deploying malaria vaccines in late 2024 to combat a disease that claimed nearly 200,000 lives domestically that year. While the national rollout remains gradual, 1.8 million doses have been administered. Currently, the program is active in four of Nigeria's 36 states, focusing on protecting children under five years old.

## Clinical Impact Observed

In Bayelsa state, health officials report an 18-percent reduction in malaria prevalence among children under five. Local clinics in areas like Oruma have noted a significant decline in severe cases, including those previously progressing to fatal seizures. Parents report that vaccinated children experience only mild symptoms, reducing the financial burden of medication.

## Immunization Protocol Details

The vaccination regime requires a four-part series administered over the first 15 months of an infant's life. While the vaccine does not provide total immunity, it offers critical protection during the most vulnerable developmental years. Health workers emphasize that this schedule is essential for maintaining efficacy despite the vaccine's fading protection.

## Logistical Distribution Challenges

Reaching remote villages in the Niger Delta requires navigating complex terrain, including travel by boat through winding creeks. Health workers have adopted home-visit strategies to minimize dropout rates among families who cannot afford travel costs. These efforts are crucial for reaching populations in areas lacking basic road infrastructure and medical access.

## Economic and Structural Barriers

Despite regional oil wealth, Bayelsa state faces significant gaps in primary health care infrastructure, often attributed to historical underinvestment. Many families struggle with the 5,000 naira cost of standard malaria drugs. Consequently, the vaccine rollout serves as a vital intervention where preventative measures like bed nets have previously lagged behind.

## Health Worker Conditions

Field staff operate in challenging environments, often working near oil pipelines guarded by armed men. To support their mission, organizations provide practical equipment like rubber boots and raincoats for trekking through tropical elements. These workers remain the primary link between the vaccine supply and the most isolated, high-risk rural communities.

## Broader Context of Malaria

Malaria remains an intractable killer, with children under five accounting for over 75 percent of all malaria-related deaths across Africa. Nigeria, as Africa’s most populous nation, faces 68.5 million annual infections. The vaccine is considered a breakthrough, yet experts stress it must complement existing public health infrastructure and sanitation efforts.

## Future Outlook and Sustainability

The success of the current campaign depends on sustained coordination between state authorities and private sector partners. While local outcomes are encouraging, the long-term goal is to scale coverage across all 36 states. Future efforts must address systemic corruption and infrastructure deficits to ensure consistent access to life-saving immunization services.

## Sources covering this story

- [eNCA — Nigeria Scales Up Malaria Vaccination Efforts](https://www.enca.com/opinion/jab-jab-house-house-nigeria-slowly-rolls-out-malaria-vaccine)
- [Medical Xpress — Nigeria Launches Targeted Malaria Vaccination Campaign](https://medicalxpress.com/news/2026-11-jab-house-nigeria-slowly-malaria.html)

---

_Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._
